Tag: US FDA
-
FDA Grants First Full Approval for Treatment of Lymphoma in Dogs
Today, the U.S. Food and Drug Administration fully approved Tanovea (rabacfosadine injection) to treat lymphoma in dogs. Lymphoma, also called lymphosarcoma, is a type of cancer that can affect many species, including dogs. Tanovea is the first conditionally approved new animal drug for dogs to achieve the FDA’s full approval. Tanovea was approved using the…